Loading…
Maze Therapeutics, Inc. is projected to rise to $30.91 by 2027, a +19% move from its current price of $26.05. MAZE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $25.45 | $26.06 | $26.68 | +0.03% |
| May 30 | $25.21 | $26.06 | $26.95 | +0.05% |
| May 31 | $25.03 | $26.07 | $27.16 | +0.08% |
| Jun 1 | $24.87 | $26.08 | $27.34 | +0.10% |
| Jun 2 | $24.74 | $26.08 | $27.50 | +0.13% |
| Jun 3 | $24.63 | $26.09 | $27.64 | +0.15% |
| Jun 4 | $24.52 | $26.10 | $27.78 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $24.52 | $26.10 | $27.78 | +0.18% |
| Week 2 | $23.93 | $26.14 | $28.56 | +0.36% |
| Week 3 | $23.51 | $26.19 | $29.18 | +0.54% |
| Week 4 | $23.16 | $26.24 | $29.73 | +0.72% |
| Week 5 | $22.86 | $26.29 | $30.22 | +0.90% |
| Week 6 | $22.60 | $26.33 | $30.68 | +1.09% |
| Week 7 | $22.36 | $26.38 | $31.12 | +1.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Maze Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule precision medicines for the treatment of kidney and metabolic diseases in the United States.
Maze Therapeutics, Inc. (MAZE) is a healthcare company with a current price of $25.78 and a market capitalization of $1.43B. It ranks 2271 by market cap among peers. The asset sits in the Healthcare sector and is positioned as a clinical-stage biotechnology company.
A major floor 13.4% below — a decisive break under it would weaken the trend.
The nearest floor, 6.1% below — buyers have tended to step in here.
The nearest ceiling, 7.8% above — a clean break opens room to run.
A major ceiling 99.0% above — clearing it would confirm fresh momentum.
Key MAZE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of MAZE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $25.79 | Buy | $25.87 | Buy |
| MA 10 | $25.69 | Buy | $25.79 | Buy |
| MA 20 | $25.95 | Buy | $26.23 | Sell |
| MA 50 | $29.68 | Sell | $29.76 | Sell |
| MA 100 | $37.29 | Sell | $32.69 | Sell |
| MA 200 | $32.93 | Sell | $31.25 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.53 | Neutral |
| Stoch RSI (14) | 88.01 | Sell |
| CCI (20) | 10.78 | Neutral |
| Williams %R (14) | -36.40 | Info |
| MACD (12,26,9) | 0.40 | Buy |
| ROC (12) | 0.08 | Buy |
| Bollinger %B (20,2) | 0.53 | Neutral |
| Stochastic %K (14) | 63.60 | Neutral |
| TRIX (15) | -0.69 | Sell |
| Awesome (5,34) | -0.50 | Sell |
| Ultimate (7,14,28) | 53.18 | Neutral |
| Momentum (10) | 0.27 | Buy |
| Aroon Osc (25) | -48.00 | Sell |
| Hull MA (9) | 26.25 | Sell |
| ADX (14) | 25.63 | Sell |
| ATR (14) | 0.62 | Info |
The near-term technical picture shows a NEUTRAL sentiment with RSI(14) at 40. The stock trades around its indicators: SMA50 at $30.66 and SMA200 at $32.80, painting a sense of a mixed near-term trend. Traders might watch key levels near support at $24.46 and resistance at $28.09, with a 30-day price range from $21.92 to $30.32.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $24.46 | $26.05 | $33.82 | 0% | Neutral | |
| $24.64 | $30.91 | $41.01 | +19% | Neutral | |
| $25.57 | $32.90 | $45.16 | +26% | Bullish | |
| $30.39 | $39.96 | $56.34 | +53% | Bullish | |
| $37.00 | $49.58 | $71.51 | +90% | Bullish | |
| $38.32 | $52.24 | $76.88 | +101% | Bullish | |
| $40.01 | $55.42 | $83.05 | +113% | Bullish | |
| $42.18 | $59.31 | $90.35 | +128% | Bullish | |
| $43.99 | $62.76 | $97.04 | +141% | Bullish | |
| $47.57 | $68.80 | $107.89 | +164% | Bullish | |
| $69.05 | $106.28 | $176.80 | +308% | Bullish | |
| $123.92 | $212.16 | $384.77 | +714% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $24.46 | $26.05 | $30.58 | +0.00% |
| June 2026 | $22.65 | $26.58 | $31.89 | +2.02% |
| July 2026 | $22.55 | $26.67 | $32.42 | +0.35% |
| August 2026 | $21.91 | $26.07 | $32.00 | -2.24% |
| September 2026 | $22.00 | $26.31 | $32.56 | +0.93% |
| October 2026 | $22.61 | $27.17 | $33.86 | +3.23% |
| November 2026 | $22.47 | $27.11 | $34.00 | -0.21% |
| December 2026 | $22.13 | $26.81 | $33.82 | -1.11% |
Click any year to see its month-by-month MAZE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Maze Therapeutics, Inc.'s 2026 outlook centres on $26.05, within a $24.46 to $33.82 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, MAZE could reach as high as $41.01, with a base case around $30.91 and support toward $24.64 — roughly +19% from $26.05. A consolidation phase looks the most probable path here.
Expect MAZE to range from $25.57 to $45.16 through 2028. The $32.90 average target implies a +26% move from current prices. That is up +6% on the projected 2027 average. Momentum favours further upside here.
The MAZE price prediction for 2029 points to an average of $39.96 (low $30.39, high $56.34) — a potential gain of +53% on today's $26.05. Buyers look set to stay in control over this stretch.
In 2030, MAZE is projected to trade between $37.00 and $71.51, averaging $49.58 — a potential gain of +90% from today's $26.05. That is up +24% on the projected 2029 average. Momentum favours further upside here.
Maze Therapeutics, Inc.'s 2031 outlook centres on $52.24, within a $38.32 to $76.88 range. That is up +5% on the projected 2030 average. That marks a +101% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, MAZE could reach as high as $83.05, with a base case around $55.42 and support toward $40.01 — roughly +113% from $26.05. Momentum favours further upside here.
Expect MAZE to range from $42.18 to $90.35 through 2033. The $59.31 average target implies a +128% move from current prices. That is up +7% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The MAZE price prediction for 2034 points to an average of $62.76 (low $43.99, high $97.04) — a potential gain of +141% on today's $26.05. Momentum favours further upside here.
In 2035, MAZE is projected to trade between $47.57 and $107.89, averaging $68.80 — a potential gain of +164% from today's $26.05. That is up +10% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Maze Therapeutics, Inc.'s 2040 outlook centres on $106.28, within a $69.05 to $176.80 range. That is up +54% on the projected 2035 average. That marks a +308% change versus current levels. Momentum favours further upside here.
By 2050, MAZE could reach as high as $384.77, with a base case around $212.16 and support toward $123.92 — roughly +714% from $26.05. Buyers look set to stay in control over this stretch.
Investing $1,000 in MAZE today (≈ 38.387716 MAZE) could be worth
$8,144.4
+$7,144.4 (+714%) by 2050 · US Dollar
Based on the average projected MAZE price of $212.16 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in MAZEwould be worth at today's price.
$1,000 invested in MAZE on May 27, 2025 (≈ 89.285716 MAZE) would be worth
$2,325.89
+$1,325.89 (+132.6%) today · 2.33× · US Dollar
Based on a MAZE entry price of $11.2 vs. today's $26.05.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $25.03 | $1,040.75 | +4.1% |
| 1 month ago | $26.47 | $984.13 | -1.6% |
| 3 months ago | $45.84 | $568.28 | -43.2% |
| 6 months ago | $37.75 | $690.07 | -31.0% |
| 1 year ago | $11.2 | $2,325.89 | +132.6% |
| All time (1.3y) ago | $15.95 | $1,633.23 | +63.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our MAZE forecast.
Our base-case forecast reaches $52.00 around 2031.
Implied market cap at $52.00: $2.88B
The multi-year forecast outlines a bullish trajectory beyond 2026, with the 2026 average price at $25.78 and a 0% ROI, followed by rising averages: 2027 avg $30.24 (ROI 17.3%), 2028 avg $31.60 (ROI 22.6%), 2029 avg $38.45 (ROI 49.1%), 2030 avg $47.86 (ROI 85.7%), 2031 avg $49.62 (ROI 92.5%), 2032 avg $52.64 (ROI 104.2%), 2033 avg $56.38 (ROI 118.7%), 2034 avg $58.63 (ROI 127.4%), 2035 avg $64.30 (ROI 149.4%), 2040 avg $97.88 (ROI 279.7%), and 2050 avg $194.09 (ROI 652.9%). The forecast shows a sustained BULLISH sentiment from 2028 onward with substantial upside toward 2050, but these are estimates, not guarantees, and depend on market conditions and other factors.
Tap a question to reveal the answer.
2026 min $24.46, avg $25.78, max $33.44 with ROI 0%; 2030 avg $47.86, min $35.44, max $69.70, ROI 85.7%, sentiment BULLISH.
The forecast shows a bullish trajectory with rising averages from 2027 onward and ROI increasing to 85.7% by 2030 and up to 652.9% by 2050, though estimates are not guaranteed.
Yes. The 2035 max is $102.09, the 2040 max is $165.17, and the 2050 max is $358.02.
Current price is $25.78. RSI(14) is 40 and sentiment is NEUTRAL. SMA50 is $30.66 and SMA200 is $32.80. The 30-day range is $21.92 to $30.32, with support at $24.46 and resistance at $28.09; annualized volatility is 50%.
Rank 2271 with a market capitalization of $1.43B.
Maze Therapeutics, Inc. Community Discussion
0Share your Maze Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.